- Home
- ZTS vs ROP Comparison
ZTS vs ROP Comparison
Compare ZTS & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTS
- ROP
- Stock Information
- Founded
- ZTS 1952
- ROP 1981
- Country
- ZTS United States
- ROP United States
- Employees
- ZTS 13800
- ROP N/A
- Industry
- ZTS Biotechnology: Pharmaceutical Preparations
- ROP Industrial Machinery/Components
- Sector
- ZTS Health Care
- ROP Industrials
- Exchange
- ZTS Nasdaq
- ROP Nasdaq
- Market Cap
- ZTS 66.2B
- ROP 58.3B
- IPO Year
- ZTS 2013
- ROP 1992
- Fundamental
- Price
- ZTS $149.11
- ROP $513.22
- Analyst Decision
- ZTS Buy
- ROP Buy
- Analyst Count
- ZTS 8
- ROP 12
- Target Price
- ZTS $200.25
- ROP $633.18
- AVG Volume (30 Days)
- ZTS 2.4M
- ROP 798.5K
- Earning Date
- ZTS 11-03-2025
- ROP 10-22-2025
- Dividend Yield
- ZTS 1.33%
- ROP 0.64%
- EPS Growth
- ZTS 14.10
- ROP 5.46
- EPS
- ZTS 5.82
- ROP 14.24
- Revenue
- ZTS $9,385,000,000.00
- ROP $7,468,100,000.00
- Revenue This Year
- ZTS $3.90
- ROP $13.79
- Revenue Next Year
- ZTS $6.00
- ROP $8.34
- P/E Ratio
- ZTS $25.89
- ROP $36.34
- Revenue Growth
- ZTS 5.27
- ROP 13.59
- 52 Week Low
- ZTS $139.70
- ROP $499.47
- 52 Week High
- ZTS $200.33
- ROP $595.17
- Technical
- Relative Strength Index (RSI)
- ZTS 40.96
- ROP 39.57
- Support Level
- ZTS $148.38
- ROP $509.13
- Resistance Level
- ZTS $152.00
- ROP $524.90
- Average True Range (ATR)
- ZTS 2.70
- ROP 7.45
- MACD
- ZTS -0.58
- ROP -0.29
- Stochastic Oscillator
- ZTS 25.98
- ROP 19.10
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About ROP Roper Technologies Inc.
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.